The investigational oral therapy tucatinib, when added to standard trastuzumab and capecitabine, resulted in a “clinically meaningful” lower risk of disease progression or death compared with placebo
Medscape Medical News …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
